The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma

Small nucleolar RNAs (snoRNAs) and small Cajal body-specific RNAs (scaRNAs) are non-coding RNAs involved in the maturation of other RNA molecules and generally located in the introns of host genes. It is now emerging that altered sno/scaRNAs expression may have a pathological role in cancer. This study elucidates the patterns of sno/scaRNAs expression in multiple myeloma (MM) by profiling purified malignant plasma cells from 55 MMs, 8 secondary plasma cell leukemias (sPCLs) and 4 normal controls. Overall, a global sno/scaRNAs downregulation was found in MMs and, even more, in sPCLs compared with normal plasma cells. Whereas SCARNA22 resulted the only sno/scaRNA characterizing the translocation/cyclin D4 (TC4) MM, TC2 group displayed a distinct sno/scaRNA signature overexpressing members of SNORD115 and SNORD116 families located in a region finely regulated by an imprinting center at 15q11, which, however, resulted overall hypomethylated in MMs independently of the SNORD115 and SNORD116 expression levels. Finally, integrative analyses with available gene expression and genome-wide data revealed the occurrence of significant sno/scaRNAs/host genes co-expression and the putative influence of allelic imbalances on specific snoRNAs expression. Our data extend the current view of sno/scaRNAs deregulation in cancer and add novel information to the bio-molecular complexity of plasma cell dyscrasias.

[1]  Geoffrey J. Barton,et al.  Human miRNA Precursors with Box H/ACA snoRNA Features , 2009, PLoS Comput. Biol..

[2]  A. Neri,et al.  A SNP microarray and FISH‐based procedure to detect allelic imbalances in multiple myeloma: An integrated genomics approach reveals a wide gene dosage effect , 2009, Genes, chromosomes & cancer.

[3]  C. Gorrini,et al.  Release of eIF6 (p27BBP) from the 60S subunit allows 80S ribosome assembly , 2003, Nature.

[4]  P. Brousset,et al.  Specific small nucleolar RNA expression profiles in acute leukemia , 2012, Leukemia.

[5]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Markus Brameier,et al.  Human box C/D snoRNAs with miRNA like functions: expanding the range of regulatory RNAs , 2010, Nucleic Acids Res..

[7]  P. Tassone,et al.  MicroRNAs in the pathobiology of multiple myeloma. , 2012, Current cancer drug targets.

[8]  R. Myers,et al.  Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data , 2005, Nucleic acids research.

[9]  F. Jiang,et al.  Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis , 2011, Oncogene.

[10]  Laura Mosca,et al.  An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma , 2008, BMC medical genomics.

[11]  D. Basso,et al.  Upregulation of translational machinery and distinct genetic subgroups characterise hyperdiploidy in multiple myeloma , 2007, British journal of haematology.

[12]  Ming Zhang,et al.  Sno/scaRNAbase: a curated database for small nucleolar RNAs and cajal body-specific RNAs , 2006, Nucleic Acids Res..

[13]  Bart Barlogie,et al.  Genetics and Cytogenetics of Multiple Myeloma , 2004, Cancer Research.

[14]  L. Corchete,et al.  Genomic analysis of high-risk smoldering multiple myeloma , 2012, Haematologica.

[15]  Gabriele Sales,et al.  Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma. , 2009, Blood.

[16]  A. Hüttenhofer,et al.  The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A. , 2001, Human molecular genetics.

[17]  Taciana Kasciukovic,et al.  A novel TBP‐associated factor of SL1 functions in RNA polymerase I transcription , 2007, The EMBO journal.

[18]  Trevor J Pugh,et al.  Initial genome sequencing and analysis of multiple myeloma , 2011, Nature.

[19]  Fiona M Ross,et al.  Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma. , 2011, Blood.

[20]  A. Baccarelli,et al.  Differential repetitive DNA methylation in multiple myeloma molecular subgroups. , 2009, Carcinogenesis.

[21]  Yongsheng Huang,et al.  A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. , 2006, Blood.

[22]  Valery Shepelev,et al.  snoTARGET shows that human orphan snoRNA targets locate close to alternative splice junctions. , 2008, Gene.

[23]  T. Chevassut,et al.  The Genetic Architecture of Multiple Myeloma , 2014, Advances in hematology.

[24]  Leon D. Segal,et al.  Functions , 1995 .

[25]  T. Kiss.  Small Nucleolar RNAs An Abundant Group of Noncoding RNAs with Diverse Cellular Functions , 2002, Cell.

[26]  M. Behlke,et al.  Small nucleolar RNAs U32a, U33, and U35a are critical mediators of metabolic stress. , 2011, Cell metabolism.

[27]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[28]  Michelle S. Scott,et al.  Human box C/D snoRNA processing conservation across multiple cell types , 2011, Nucleic acids research.

[29]  M. Walter,et al.  Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice. , 2011, Blood.

[30]  Michelle S. Scott,et al.  From snoRNA to miRNA: Dual function regulatory non-coding RNAs , 2011, Biochimie.

[31]  P. L. Bergsagel,et al.  Advances in biology of multiple myeloma: clinical applications. , 2004, Blood.

[32]  M. Mattioli,et al.  Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses , 2005, Genes, chromosomes & cancer.

[33]  Michelle S. Scott,et al.  Identification of human miRNA precursors that resemble box C/D snoRNAs , 2011, Nucleic acids research.

[34]  J. Cavaille,et al.  The SNORD115 (H/MBII-52) and SNORD116 (H/MBII-85) gene clusters at the imprinted Prader–Willi locus generate canonical box C/D snoRNAs , 2012, Nucleic acids research.

[35]  S. Crosby,et al.  Multiple myeloma-associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stress. , 2012, The Journal of clinical investigation.

[36]  S. Volinia,et al.  Non-coding RNAs: a key to future personalized molecular therapy? , 2010, Genome Medicine.

[37]  F. Farzaneh,et al.  Are snoRNAs and snoRNA host genes new players in cancer? , 2012, Nature Reviews Cancer.

[38]  Mihaela Zavolan,et al.  The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing. , 2010, Human molecular genetics.

[39]  Laurent Lestrade,et al.  snoRNA-LBME-db, a comprehensive database of human H/ACA and C/D box snoRNAs , 2005, Nucleic Acids Res..

[40]  Kenneth C. Anderson,et al.  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group , 2003, British journal of haematology.

[41]  K. Mokbel,et al.  Evidence for a pro-apoptotic function of RACK1 in human breast cancer , 2010, Oncogene.

[42]  T. Kiss,et al.  A small nucleolar guide RNA functions both in 2′‐O‐ribose methylation and pseudouridylation of the U5 spliceosomal RNA , 2001, The EMBO journal.

[43]  D. Basso,et al.  Transcriptional features of multiple myeloma patients with chromosome 1q gain , 2007, Leukemia.

[44]  C. Li,et al.  Feature extraction and normalization algorithms for high‐density oligonucleotide gene expression array data , 2001, Journal of cellular biochemistry. Supplement.

[45]  R. Aqeilan,et al.  MicroRNAs: New Players in Multiple Myeloma , 2011, Front. Gene..

[46]  S. Bicciato,et al.  Molecular classification of multiple myeloma: a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.